当前位置: X-MOL 学术Cancer Biother. Radiopharm. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The Efficacy of Hemoglobin, Albumin, Lymphocytes, and Platelets as a Prognostic Marker for Survival in Octogenarians and Nonagenarians Undergoing Colorectal Cancer Surgery
Cancer Biotherapy and Radiopharmaceuticals ( IF 3.4 ) Pub Date : 2022-12-12 , DOI: 10.1089/cbr.2020.4725
Hasan Dagmura 1 , Emin Daldal 2 , Ismail Okan 3
Affiliation  

Objectives: With the aging population worldwide, the octogenarians are becoming a substantial group and since cancer incidence increases by age, this group of patients is becoming more affected. However, no distinct treatment algorithm has been established for elderly patients with cancer. The present study aimed to determine the prognostic value of several inflammatory parameters by comparing octogenarian patients treated surgically for colorectal cancer with their younger counterparts, as well as to predict and prevent age-related complications in this frail group of patients.

中文翻译:

血红蛋白、白蛋白、淋巴细胞和血小板作为接受结直肠癌手术的八十多岁和九十多岁患者生存的预后标志物的功效

目的:随着全球人口老龄化,八十多岁的人正在成为一个重要的群体,并且由于癌症发病率随着年龄的增长而增加,这群患者受到的影响越来越大。然而,尚未为老年癌症患者建立明确的治疗方案。本研究旨在通过比较接受结直肠癌手术治疗的八十多岁患者与较年轻的患者来确定几种炎症参数的预后价值,并预测和预防这组虚弱患者的年龄相关并发症。
更新日期:2022-12-15
down
wechat
bug